The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia
Nora Hamdani(Inserm), Philip Gorwood(Inserm), Jean-Pierre Tabeze(Centre Hospitalier René-Dubos), Nicolás Ramoz(Inserm), Claudette Boni(Inserm), Yves Sarfati(Hôpital André Mignot), J. Adès(Centre National de la Recherche Scientifique), M. Hamon(Inserm)
Cited by 79
Related Papers
How mental health care should change as a consequence of the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.9k
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy
|Nature Reviews Drug Discovery|2012|1.3k
The consequences of the COVID-19 pandemic on mental health and implications for clinical practice
|European Psychiatry|2020|1.2k